Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 61 of 123)
- Relevance
  Sort by

Anticoagulants - Global Strategic Business Report

 Report
April 2025
196 Pages
Global

From

€5339EUR$5,850USD£4,552GBP

The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
May 2022
231 Pages
Global

From

€4380EUR$4,799USD£3,734GBP

Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034

 Report
February 2024
228 Pages
Global

From

€7255EUR$7,950USD£6,186GBP

Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030

 Report
February 2025
100 Pages
Global

From

€5430EUR$5,950USD£4,630GBP

Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
283 Pages
Global

€4559EUR$4,995USD£3,887GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
57 Pages
Global

From

€3194EUR$3,500USD£2,724GBP

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
69 Pages
Global

From

€3194EUR$3,500USD£2,724GBP

B-Cell Lymphoma - Pipeline Insight, 2025

 Clinical Trials
March 2025
450 Pages
Global

From

€4563EUR$5,000USD£3,891GBP

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
May 2022
365 Pages
Global

From

€4380EUR$4,799USD£3,734GBP

Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
38 Pages
Global

From

€3194EUR$3,500USD£2,724GBP

Prostate Cancer - Pipeline Insight, 2024

 Clinical Trials
April 2024
180 Pages
Global

From

€2738EUR$3,000USD£2,335GBP

Non-Hodgkin Lymphoma (NHL) Therapeutics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

 Report
April 2024
180 Pages
Global

From

€4107EUR$4,500USD£3,502GBP

Follicular Lymphoma - Pipeline Insight, 2024

 Clinical Trials
December 2024
180 Pages
Global

From

€2282EUR$2,500USD£1,945GBP

Migraine - Global Drug Forecast and Market Analysis to 2030

 Report
November 2021
131 Pages
Global

From

€13685EUR$14,995USD£11,669GBP

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
1079 Pages
Global

From

€2282EUR$2,500USD£1,945GBP

Rheumatoid Arthritis - Pipeline Review, H2 2020

 Drug Pipelines
July 2020
1191 Pages
Global

From

€2282EUR$2,500USD£1,945GBP

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

 Drug Pipelines
August 2020
693 Pages
Global

From

€1825EUR$2,000USD£1,556GBP

Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Forecast to 2028

 Report
January 2024
293 Pages
Global

From

€4517EUR$4,950USD£3,852GBP

Company Snapshots: UK Pharmaceuticals

 Newsletter
April 2025
35 Pages
United Kingdom

From

€274EUR$300USD£233GBP

Company Snapshots: US Pharmaceuticals

 Newsletter
April 2025
35 Pages
United States

From

€274EUR$300USD£233GBP

2,452 Results (Page 61 of 123)
- 1
- 59
- 60
- 61
- 62
- 63

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.